JP7270901B2 - 男性の避妊のための非ホルモン性組成物および方法 - Google Patents

男性の避妊のための非ホルモン性組成物および方法 Download PDF

Info

Publication number
JP7270901B2
JP7270901B2 JP2021500350A JP2021500350A JP7270901B2 JP 7270901 B2 JP7270901 B2 JP 7270901B2 JP 2021500350 A JP2021500350 A JP 2021500350A JP 2021500350 A JP2021500350 A JP 2021500350A JP 7270901 B2 JP7270901 B2 JP 7270901B2
Authority
JP
Japan
Prior art keywords
composition
silodosin
alpha
male
contraception
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021500350A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019180217A5 (ko
JP2021518438A (ja
Inventor
グラウィ，ギヨーム エル
グラウィ，メフディ エル
ペラン，フィリップ
ドルーピー，ステファン
アガトン－メリアウ，ベロニク
Original Assignee
ファーマジョール インターナショナル
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファーマジョール インターナショナル filed Critical ファーマジョール インターナショナル
Publication of JP2021518438A publication Critical patent/JP2021518438A/ja
Publication of JPWO2019180217A5 publication Critical patent/JPWO2019180217A5/ja
Application granted granted Critical
Publication of JP7270901B2 publication Critical patent/JP7270901B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
JP2021500350A 2018-03-23 2019-03-22 男性の避妊のための非ホルモン性組成物および方法 Active JP7270901B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862763129P 2018-03-23 2018-03-23
EP18305328 2018-03-23
EP18305328.9 2018-03-23
US62/763,129 2018-03-23
PCT/EP2019/057267 WO2019180217A1 (en) 2018-03-23 2019-03-22 Non-hormonal compositions and methods for male contraception

Publications (3)

Publication Number Publication Date
JP2021518438A JP2021518438A (ja) 2021-08-02
JPWO2019180217A5 JPWO2019180217A5 (ko) 2022-03-30
JP7270901B2 true JP7270901B2 (ja) 2023-05-11

Family

ID=65955198

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021500350A Active JP7270901B2 (ja) 2018-03-23 2019-03-22 男性の避妊のための非ホルモン性組成物および方法

Country Status (17)

Country Link
US (3) US10912762B2 (ko)
EP (2) EP3750538A1 (ko)
JP (1) JP7270901B2 (ko)
KR (1) KR102496504B1 (ko)
CN (1) CN112074269A (ko)
AU (1) AU2019237228B2 (ko)
BR (1) BR112020018925A2 (ko)
CA (1) CA3094016C (ko)
DK (1) DK3562485T3 (ko)
ES (1) ES2813084T3 (ko)
IL (1) IL277372B2 (ko)
MA (1) MA53626A (ko)
MX (1) MX2020009937A (ko)
PL (1) PL3562485T3 (ko)
PT (1) PT3562485T (ko)
SG (1) SG11202008794TA (ko)
WO (1) WO2019180217A1 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202008794TA (en) * 2018-03-23 2020-10-29 Laboratoires Major Non-hormonal compositions and methods for male contraception
US20240180871A1 (en) * 2022-11-23 2024-06-06 Pharmajor Incorporated Modified-release silodosin compositions and use thereof in methods for male contraception

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080242717A1 (en) 2007-02-28 2008-10-02 Fumiyasu Sato Methods for treating benign prostatic hyperplasia

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1091276A (en) 1911-12-09 1914-03-24 Basf Ag Producing unsaturated terpene hydrocarbons.
US4210644A (en) 1978-02-23 1980-07-01 The Johns Hopkins University Male contraception
DE4308406C1 (de) 1993-03-12 1994-06-16 Jenapharm Gmbh Kombinationspräparat zur Kontrazeption
ATE355844T1 (de) 2000-02-15 2007-03-15 Schering Ag Zusammensetzung zur männlichen kontrazeption, norethisteron und testosteron undecanoat enthaltend
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
CN101316934A (zh) * 2005-09-29 2008-12-03 拜耳医药保健股份公司 用于治疗泌尿系统疾病的pde抑制剂及其组合
EP1931797A2 (en) * 2005-09-29 2008-06-18 Bayer HealthCare AG Pde inhibitors and combinations thereof for the treatment of urological disorders
KR20090094811A (ko) * 2006-10-05 2009-09-08 파나세아 바이오테크 리미티드 새로운 형태의 주입형 데포조성물 및 이를 조제하기 위한 방법
GB0700893D0 (en) 2007-01-17 2007-02-21 King S College London Male contraceptive
US20120184591A1 (en) * 2011-01-13 2012-07-19 Watson Pharmaceuticals, Inc. Methods for treating prostatitis
CN102283816B (zh) 2011-08-05 2013-09-11 北京海步国际医药科技发展有限公司 西洛多辛缓释片剂及其制备方法
WO2014118606A2 (en) * 2013-01-29 2014-08-07 Alembic Pharmaceuticals Limited A novel process for the preparation of silodosin
WO2016051782A1 (ja) 2014-09-30 2016-04-07 キッセイ薬品工業株式会社 苦味を有する薬剤の苦味をマスキングした経口投与製剤
US20170049834A1 (en) * 2015-08-18 2017-02-23 Golden Biotechnology Corporation Benign prostatic hyperplasia add-on therapy
SG11202008794TA (en) * 2018-03-23 2020-10-29 Laboratoires Major Non-hormonal compositions and methods for male contraception

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080242717A1 (en) 2007-02-28 2008-10-02 Fumiyasu Sato Methods for treating benign prostatic hyperplasia

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Andrology，2015年，Vol.3，pp.1076-1081
Contraception，1988年，Vol.37, No.6，pp.621-629
Indian Journal of Urology，2018年01月01日，Vol.34, Supplement 1，p.S7, Abstract No.BKP02
International Journal of Impotence Research，2009年，Vol.21，pp.306-310
Medical Hypotheses，2009年，Vol.73，pp.140-141
Urology，2012年，Vol.80，pp.614-617

Also Published As

Publication number Publication date
IL277372B2 (en) 2023-09-01
US20230145374A1 (en) 2023-05-11
US11583518B2 (en) 2023-02-21
EP3562485B1 (en) 2020-07-01
US20210113526A1 (en) 2021-04-22
PL3562485T3 (pl) 2020-11-16
EP3562485A1 (en) 2019-11-06
CN112074269A (zh) 2020-12-11
IL277372B1 (en) 2023-05-01
SG11202008794TA (en) 2020-10-29
MX2020009937A (es) 2022-09-30
US20190290615A1 (en) 2019-09-26
EP3750538A1 (en) 2020-12-16
AU2019237228B2 (en) 2023-06-08
EP3562485B8 (en) 2020-08-19
IL277372A (en) 2020-11-30
CA3094016C (en) 2023-10-10
DK3562485T3 (da) 2020-08-24
RU2020134408A3 (ko) 2022-04-29
KR20200135978A (ko) 2020-12-04
KR102496504B1 (ko) 2023-02-06
AU2019237228A1 (en) 2020-10-01
ES2813084T3 (es) 2021-03-22
PT3562485T (pt) 2020-08-27
US11951095B2 (en) 2024-04-09
US10912762B2 (en) 2021-02-09
WO2019180217A1 (en) 2019-09-26
MA53626A (fr) 2022-03-09
BR112020018925A2 (pt) 2020-12-29
CA3094016A1 (en) 2019-09-26
RU2020134408A (ru) 2022-04-29
JP2021518438A (ja) 2021-08-02

Similar Documents

Publication Publication Date Title
JP5421775B2 (ja) オキシコドンを含む顆粒及び口腔内崩壊錠剤
US11951095B2 (en) Non-hormonal compositions and methods for male contraception
JP7374885B2 (ja) 子宮内膜症、子宮筋腫、多嚢胞性卵巣症候群又は腺筋症を治療するための医薬製剤
US20190054088A1 (en) Pharmaceutical Formulations for Treating Endometriosis, Uterine Fibroids, Polycystic Ovary Syndrome or Adenomyosis
US20220008415A1 (en) Combination Therapy for Male Sexual Dysfunction
TWI240638B (en) A film-coated solid-dosage form pharmaceutical composition
US20110250268A1 (en) Compositions and Methods for Inhibiting Gastric Acid Secretion
RU2799756C2 (ru) Применение композиции для негормональной контрацепции и упаковка
JPWO2003075919A1 (ja) 塩酸ピルジカイニド含有錠剤（乾式）
US20240180871A1 (en) Modified-release silodosin compositions and use thereof in methods for male contraception
WO2017100324A1 (en) Combination therapy for treating female hypoactive sexual desire disorders
JP2006076956A (ja) 胃炎の治療・予防用配合剤
TW202339709A (zh) 微粒化索拉貝隆(solabegron)之組成物及使用方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220318

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220318

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20220318

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220412

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220712

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220809

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221004

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230209

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230314

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20230327

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230327

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230412

R150 Certificate of patent or registration of utility model

Ref document number: 7270901

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150